CD4 and neoplasm: Using a non-T cell receptor transgenic, immunocompetent tumor model, researchers demonstrated that the eradication of aggressive cancers through T cell targeting of tumor stroma crucially depends on the cooperation between CD4+ and CD8+ T cells.